MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

NCT06044493 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Myreptic-N Tablet
DRUG: Mycophenolate mofetil Tablet/Capsule

Sponsor

Chong Kun Dang Pharmaceutical